Showing 541 - 560 results of 2,530 for search '"vaccines"', query time: 0.06s Refine Results
  1. 541
  2. 542

    Dynamical analysis of a complex competitive two-strain epidemic network model with vaccination by A. Abdelkhalek, A.H. Abdel Kader, I.L. El-Kalla, A. Elsaid, Amr Elsonbaty, K.S. Nisar

    Published 2025-03-01
    “…Therefore, this work proposes a new complex competitive two-strain epidemic network model that incorporates vaccination. We derive the mathematical model, compute the disease-free equilibrium point, and determine its stability conditions. …”
    Get full text
    Article
  3. 543

    Benign Recurrent Sixth (Abducens) Nerve Palsy following Measles-Mumps-Rubella Vaccination by Areti Bourtoulamaiou, Sohraab Yadav, Harish Nayak

    Published 2015-01-01
    “…Here, we present the case of a 2-year-old Caucasian girl who developed recurrent 6th nerve palsy following vaccination with the measles-mumps-rubella (MMR) vaccine. …”
    Get full text
    Article
  4. 544

    BNT162b2 COVID-19 Vaccine Induced Immune Thrombocytopenic Purpura by A. K. Ghosh, S. Bhushan, L. D. R. Lopez, D. Sampat, Z. Salah, C. A. Hatoum

    Published 2022-01-01
    “…Immune thrombocytopenic purpura (ITP) has been reported following vaccinations such as MMR as well as after viral infections such as hepatitis C and HIV. …”
    Get full text
    Article
  5. 545

    COVID-19 vaccine misinformation in English-language news media: retrospective cohort study by Peter Lurie, Jordan Adams, Mark Lynas, Karen Stockert, Robyn Correll Carlyle, Amy Pisani, Sarah Davidson Evanega

    Published 2022-06-01
    “…Objectives To describe COVID-19 vaccine misinformation and track trends over time in traditional news media.Design Retrospective cohort study of a large database of online articles, July 2020–June 2021.Setting English-language articles from 100 news outlets with the greatest reach.Main outcome measures Numbers and percentages of articles containing COVID-19 vaccine misinformation over the study period. …”
    Get full text
    Article
  6. 546

    Self-Reported COVID-19 Vaccine Status and Barriers for Pediatric Emergency Patients and Caregivers by Amanda M. Szarzanowicz, Kendra Fabian, Maya Alexandri, Carly A. Robinson, Sonia Singh, Michael Wallace, Michelle D. Penque, Nan Nan, Changxing Ma, Bradford Z. Reynolds, Bethany W. Harvey, Heidi Suffoletto, E. Brooke Lerner

    Published 2024-10-01
    “…Objective: This study determined if the caregivers of children in the emergency department (ED) have the same COVID-19 vaccination status as the child, the reasons they chose to not vaccinate the child, and self-identified barriers to vaccination to determine if the ED is appropriate for vaccination intervention. …”
    Get full text
    Article
  7. 547
  8. 548

    Reevaluating the Concept of Treating Experimental Tumors with a Mixed Bacterial Vaccine: Coley’s Toxin by C. Maletzki, U. Klier, W. Obst, B. Kreikemeyer, M. Linnebacher

    Published 2012-01-01
    “…Several decades after Coley’s initial work, we here systematically analyzed tumoricidal as well as immunostimulatory effects of the historical preparation Coley’s Toxin (CT), a safe vaccine made of heat-inactivated S. pyogenes and S. marcescens. …”
    Get full text
    Article
  9. 549

    The comparative studies of Borneo plant extracts to increases vaccine efficacy in tilapia, Oreochromis niloticus by Esti Handayani Hardi, Komsanah Sukarti, Maulina Agriandini, Irawan Wijaya Kusuma, Rudi Agung Nugroho

    Published 2018-07-01
    “…ABSTRACT   This study was investigated the adjuvant effect of Boesenbergia pandurata (BP), Zingiber zerumbet (ZZ), Solanum ferox (SF) on protection of tilapia with injection Pseudomonas sp. (Pseumulvacc) vaccination. The extract concentrations of BP (600 mg/L), ZZ (200 mg/L), and SF (900 mg/L) were combined with the vaccine, ratio between vaccine and extract was 1:1. …”
    Get full text
    Article
  10. 550
  11. 551

    Artemia sp. as a DNA vaccine vector for common carp Cyprinus carpio larvae by Sri Nuryati, Sekar Sulistyaning Hadiwibowo, . Alimuddin

    Published 2014-01-01
    “…Bacteria containing plasmid Krt-GP-11 as vaccine is served through Artemia sp. as a vector. …”
    Get full text
    Article
  12. 552

    Understanding Human Papillomavirus Vaccination Hesitancy in Japan Using Social Media: Content Analysis by Junyu Liu, Qian Niu, Momoko Nagai-Tanima, Tomoki Aoyama

    Published 2025-02-01
    “… BackgroundDespite the reinstatement of proactive human papillomavirus (HPV) vaccine recommendations in 2022, Japan continues to face persistently low HPV vaccination rates, which pose significant public health challenges. …”
    Get full text
    Article
  13. 553

    Mathematical Modelling of COVID-19 Transmission Dynamics with Vaccination: A Case Study in Ethiopia by Sileshi Sintayehu Sharbayta, Henok Desalegn Desta, Tadesse Abdi

    Published 2023-01-01
    “…In this work, we consider a mathematical model of COVID-19 transmission with double-dose vaccination strategy to control the disease. For the analytical analysis purpose, we divided the model into two parts: model with vaccination and without vaccination. …”
    Get full text
    Article
  14. 554

    Towards a Rational Design of an Asymptomatic Clinical Herpes Vaccine: The Old, the New, and the Unknown by Aziz Alami Chentoufi, Elizabeth Kritzer, David M. Yu, Anthony B. Nesburn, Lbachir BenMohamed

    Published 2012-01-01
    “…The best hope of controlling the herpes simplex virus type 1 and type 2 (HSV-1 and HSV-2) pandemic is the development of an effective vaccine. However, in spite of several clinical trials, starting as early as 1920s, no vaccine has been proven sufficiently safe and efficient to warrant commercial development. …”
    Get full text
    Article
  15. 555
  16. 556

    A descriptive-multivariate analysis of community knowledge, confidence, and trust in COVID-19 clinical trials amongst Ugandans working in healthcare settings. by Keneth Iceland, Kasozi, Lawrence Obado, Osuwat

    Published 2021
    Subjects: “…COVID-19 clinical trials in resource poor countries; COVID-19 vaccines; Clinical trials in Africa; COVID-19 and medical workers; vaccines, Oxford-AstraZeneca.…”
    Get full text
    Article
  17. 557
  18. 558
  19. 559
  20. 560